Tag: MRD-positive


FDA grants accelerated approval to leukemia drug for patients with MRD-positive ALL

March 30, 2018

Via: The Medical News

The U.S. Food and Drug Administration granted accelerated approval to Blincyto (blinatumomab) to treat adults and children with B-cell precursor acute lymphoblastic leukemia (ALL) who are in remission but still have minimal residual disease (MRD). MRD refers to the presence […]